USFDA successfully concludes inspection of Solara's Cuddalore facility

Solara Active Pharma Science announced the successful completion of US FDA inspection at the multi-product manufacturing facility at Cuddalore with ZERO 483s inspectional observations.

This is Company's third consecutive US FDA audit with Zero 4835. In Dec' 18 and Jan'19, the company also completed US FDA inspections at Solara Research Centre(SRC), Chennai and Ambernath manufacturing facility with zero 4833.

Powered by Capital Market - Live News